These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32452133)

  • 1. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
    Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
    Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
    Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
    Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
    Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
    Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
    PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
    Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
    Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-κB pathway in glioblastoma cells.
    Wang H; Guan Q; Nan Y; Ma Q; Zhong Y
    J Cell Biochem; 2019 Nov; 120(11):18762-18770. PubMed ID: 31265172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
    Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
    Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
    Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma.
    Yue C; Niu M; Shan QQ; Zhou T; Tu Y; Xie P; Hua L; Yu R; Liu X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):132. PubMed ID: 28946903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
    Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
    Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
    Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
    PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.
    Zheng Y; Yang W; Aldape K; He J; Lu Z
    J Biol Chem; 2013 Nov; 288(44):31488-95. PubMed ID: 24045955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
    Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
    Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
    Nicolau CA; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro.
    Jiang YW; Cheng HY; Kuo CL; Way TD; Lien JC; Chueh FS; Lin YL; Chung JG
    Environ Toxicol; 2019 Apr; 34(4):364-374. PubMed ID: 30549224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.